1. Home
  2. FLNT vs NVNO Comparison

FLNT vs NVNO Comparison

Compare FLNT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLNT
  • NVNO
  • Stock Information
  • Founded
  • FLNT 2001
  • NVNO 1987
  • Country
  • FLNT United States
  • NVNO United States
  • Employees
  • FLNT N/A
  • NVNO N/A
  • Industry
  • FLNT Advertising
  • NVNO Medical/Dental Instruments
  • Sector
  • FLNT Consumer Discretionary
  • NVNO Health Care
  • Exchange
  • FLNT Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • FLNT 47.9M
  • NVNO 71.0M
  • IPO Year
  • FLNT N/A
  • NVNO N/A
  • Fundamental
  • Price
  • FLNT $2.27
  • NVNO $5.17
  • Analyst Decision
  • FLNT Hold
  • NVNO
  • Analyst Count
  • FLNT 1
  • NVNO 0
  • Target Price
  • FLNT $3.00
  • NVNO N/A
  • AVG Volume (30 Days)
  • FLNT 23.3K
  • NVNO 137.8K
  • Earning Date
  • FLNT 08-18-2025
  • NVNO 08-08-2025
  • Dividend Yield
  • FLNT N/A
  • NVNO N/A
  • EPS Growth
  • FLNT N/A
  • NVNO N/A
  • EPS
  • FLNT N/A
  • NVNO N/A
  • Revenue
  • FLNT $243,850,000.00
  • NVNO N/A
  • Revenue This Year
  • FLNT N/A
  • NVNO N/A
  • Revenue Next Year
  • FLNT $11.62
  • NVNO N/A
  • P/E Ratio
  • FLNT N/A
  • NVNO N/A
  • Revenue Growth
  • FLNT N/A
  • NVNO N/A
  • 52 Week Low
  • FLNT $1.50
  • NVNO $2.03
  • 52 Week High
  • FLNT $3.83
  • NVNO $5.92
  • Technical
  • Relative Strength Index (RSI)
  • FLNT 54.88
  • NVNO 66.07
  • Support Level
  • FLNT $1.90
  • NVNO $4.65
  • Resistance Level
  • FLNT $3.05
  • NVNO $5.13
  • Average True Range (ATR)
  • FLNT 0.30
  • NVNO 0.40
  • MACD
  • FLNT 0.02
  • NVNO 0.06
  • Stochastic Oscillator
  • FLNT 32.17
  • NVNO 73.05

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: